IDRI Trademark

Trademark Overview


On Tuesday, July 28, 2015, a trademark application was filed for IDRI with the United States Patent and Trademark Office. The USPTO has given the IDRI trademark a serial number of 86707100. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, November 10, 2023. This trademark is owned by Infectious Disease Research Institute. The IDRI trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceutical preparations for the treatment of tuberculosis, leishmaniasis, malaria, leprosy, pandemic flu, and HIV; vaccines, adjuvants for use with vaccines; biologic preparations, diagnostic agents and pharmaceutical preparations, namely, a drug delivery system comprising polymer-based oral tablets for the continuous release of a wide variety of therapeutic agents for use in connection with humans and animals for the treatment of tuberculosis, leishmaniasis, malaria, leprosy, pandemic flu, and HIV

Medical and scientific research in the fields of vaccines, pharmaceuticals, biologics, vaccines, adjuvants, adjuvant formulations, biologic formulations, drug delivery, diagnostics, and medical therapeutics; product research and development in the fields of pharmaceuticals, vaccines, diagnostics, adjuvants, adjuvant formulations, biologic formulations and drug delivery
idri

General Information


Serial Number86707100
Word MarkIDRI
Filing DateTuesday, July 28, 2015
Status710 - CANCELLED - SECTION 8
Status DateFriday, November 10, 2023
Registration Number5189026
Registration DateTuesday, April 25, 2017
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 7, 2017

Trademark Statements


Goods and ServicesPharmaceutical preparations for the treatment of tuberculosis, leishmaniasis, malaria, leprosy, pandemic flu, and HIV; vaccines, adjuvants for use with vaccines; biologic preparations, diagnostic agents and pharmaceutical preparations, namely, a drug delivery system comprising polymer-based oral tablets for the continuous release of a wide variety of therapeutic agents for use in connection with humans and animals for the treatment of tuberculosis, leishmaniasis, malaria, leprosy, pandemic flu, and HIV
Goods and ServicesMedical and scientific research in the fields of vaccines, pharmaceuticals, biologics, vaccines, adjuvants, adjuvant formulations, biologic formulations, drug delivery, diagnostics, and medical therapeutics; product research and development in the fields of pharmaceuticals, vaccines, diagnostics, adjuvants, adjuvant formulations, biologic formulations and drug delivery

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, November 10, 2023
Primary Code005
First Use Anywhere DateThursday, October 31, 2002
First Use In Commerce DateThursday, October 31, 2002

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, November 10, 2023
Primary Code042
First Use Anywhere DateThursday, October 31, 2002
First Use In Commerce DateThursday, October 31, 2002

Trademark Owner History


Party NameInfectious Disease Research Institute
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressSeattle, WA 98102

Party NameInfectious Disease Research Institute
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressSeattle, WA 98102

Party NameInfectious Disease Research Institute
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressSeattle, WA 98102

Trademark Events


Event DateEvent Description
Friday, November 10, 2023CANCELLED SEC. 8 (6-YR)
Monday, April 25, 2022COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, April 25, 2017REGISTERED-PRINCIPAL REGISTER
Tuesday, February 7, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 7, 2017PUBLISHED FOR OPPOSITION
Wednesday, January 18, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, January 3, 2017LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, December 14, 2016EXPARTE APPEAL TERMINATED
Tuesday, December 13, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, December 9, 2016ASSIGNED TO LIE
Wednesday, November 23, 2016TEAS REQUEST FOR RECONSIDERATION RECEIVED
Wednesday, November 23, 2016EX PARTE APPEAL-INSTITUTED
Wednesday, November 23, 2016JURISDICTION RESTORED TO EXAMINING ATTORNEY
Wednesday, November 23, 2016EXPARTE APPEAL RECEIVED AT TTAB
Monday, May 23, 2016NOTIFICATION OF FINAL REFUSAL EMAILED
Monday, May 23, 2016FINAL REFUSAL E-MAILED
Monday, May 23, 2016FINAL REFUSAL WRITTEN
Tuesday, May 10, 2016TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, May 9, 2016CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, May 9, 2016TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, November 9, 2015NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, November 9, 2015NON-FINAL ACTION E-MAILED
Monday, November 9, 2015NON-FINAL ACTION WRITTEN
Friday, November 6, 2015ASSIGNED TO EXAMINER
Monday, August 3, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, July 31, 2015NEW APPLICATION ENTERED